Apotex's Neulasta, Neupogen Biosimilars Clear Legal Hurdles, But Approval Questions Remain

 
• By Brenda Sandburg
  
Court of Appeals for Federal Circuit Lafayette Park Across from White House Washington DC
US Court of Appeals for the Federal Circuit rules in favor of Apotex on Amgen's infringement claims.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics